Diagnostic Test Kits For β2-MG Assay
Methodology
Fluorescence Immunoassay
General Name
β2-MG Test Kit(Immunofluorescence)
Package
Test card: Aluminum foil pouch 1pc/bag, desiccant
Package size: 25pcs/box
Product Show
Intended use
The test kit is primarily for the in vitro quantitative determination of procalcitonin(β2-
MG) content in human blood serum and urine. As the composition of leucocyte antigen, β2-
MG exists in all of the nucleated cells. β2-MG releases into blood little and continuously. It
is filtrated completely in kidney and reabsorbed and degraded in kidney tubules. Its
concentration is low and steady in blood serum of healthy people. The activity of immune
system enhancing cause β2-MG release rate rises up, which makes serum concentration
goes up. Therefore, β2-MG release rate in blood serum is a sensitive index which reflects
the filtration ability of glomerulus. Kidney tubules injury can cause β2-MG concentration
goes up, so it is a good way to determine β2-MG concentration in urine for diagnosing ,
tracking and evaluating tubular interstitial renal damage.
B2-MG Serum/urine specs
Methodology | Fluorescence Immunoassay |
Specimen | serum/urine |
Measuring range | 0.1-20mg/L |
Cut-off value | 0.1mg/L |
Reaction time | 15 minutes |
Shelf life | 12months |
Clinical Significance
Sample reference range (mg/L)
Serum 1.01-2.97
Urine 0.10-0.30
Product advantage
1.Strong anti-interference ability
2.Different sample types: serum, urine
3.Wide test range:0.1-20mg/L
4.High sensitivity,
5.Good repeatability
6.Single sample test or batch test
Related Products
Inflammation/Infection
PCT(whole blood), PCT (surum), hs-CRP
Cardiovascular
NT-proBNP, D-Dimer
cTnI,CK-MB, MYO
Nephropathy
NAGL, RBP,Cys-c, mAlb, B2-MG
Gastrosis
PGⅠ/ PGⅡ/ PGR/ HP/ FOB
Rheumatism
RF
Diabetes
C-Peptide
About Us
Being an expert in automated chemiluminescence analysis , Norman owns independent and
completed intellectual property rights, and its products provide top-notch sensitivity,
precision and accuracy . Thanks to the self-developed antigens and self-manufactured
antibodies, Norman's products features minimized intra-and inter- batch difference.
After 8 years development, Norman is now on the fast track. An over 30,000m2 global
R&D center is in construction, and will hold more than 1,000 R&D engineers in the future.
R&D shapes future, and concentration determines success. Driven by the commitment to
"provide complete solution to improve human health", Norman will consistently do its
utmost to drive the IVD industry forward and contribute more to human health.
Agent Wanted
If you are interested in working with us, please feel free to contact.
